Arcutis Biotherapeutics Inc (ARQT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
14.62 -0.19 (-1.28%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 14.65 +0.03 (+0.21%) 17:30 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 71,360 | 44,755 | 30,858 | 49,569 | 13,526 |
| Cost of Goods | 6,905 | 5,503 | 3,464 | 3,256 | 2,246 |
| Gross Profit | 64,455 | 39,252 | 27,394 | 46,313 | 11,280 |
| Operating Expenses | 72,992 | 78,821 | 77,935 | 78,191 | 72,695 |
| Operating Income | -7,632 | -39,066 | -50,077 | -31,622 | -61,169 |
| Interest Expense | 5,551 | 6,653 | 7,484 | 7,480 | 7,762 |
| Other Income | 2,718 | 4,182 | 5,229 | 4,044 | 2,737 |
| Pre-tax Income | -10,465 | -41,537 | -52,332 | -35,058 | -66,194 |
| Income Tax | 323 | N/A | N/A | 324 | 90 |
| Net Income Continuous | -10,788 | -41,537 | -52,332 | -35,382 | -66,284 |
| Net Income | $-10,788 | $-41,537 | $-52,332 | $-35,382 | $-66,284 |
| EPS Basic Total Ops | -0.09 | -0.33 | -0.42 | -0.32 | -0.58 |
| EPS Basic Continuous Ops | -0.08 | -0.33 | -0.42 | -0.32 | -0.59 |
| EPS Diluted Total Ops | -0.09 | -0.33 | -0.42 | -0.32 | -0.58 |
| EPS Diluted Continuous Ops | -0.08 | -0.33 | -0.42 | -0.32 | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.33 | -0.42 | -0.32 | -0.72 |
| EBITDA(a) | $-8,270 | $-39,326 | $-52,114 | $-32,989 | $-62,256 |